Tag: recombinant DNA technology market forecast

  • Understanding the Recombinant DNA Technology Market’s Growth Prospects from 2024 to 2033

    Understanding the Recombinant DNA Technology Market’s Growth Prospects from 2024 to 2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 Forecast: What is the Projected Growth Rate for the Recombinant DNA Technology Market?

    In recent years, the recombinant DNA technology sector has witnessed substantial growth. The market size is predicted to increase from $816.9 billion in 2023 to $882.04 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 8.0%. The historic growth has been influenced by factors such as health care needs, the expansion of the biopharmaceutical industry, an upsurge in R&D investments, and the advent of personalized medicine.

    In the coming years, the recombinant DNA technology market is forecasted to flourish. The market is projected to surge to $1214.85 billion by 2028, expanding at a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this growth in the predicted period include the rise in chronic diseases, new biotech startups surfacing, increase in biotech financing, the global reach of biotech markets, and customer awareness and understanding. The forecasted period will also witness major trends such as advancements in scientific research and gene editing, cell and gene therapies, the development of RNA therapeutics, applications in rare disease treatment, and the blend of AI and data integration.

    Claim Your Free Sample of the Global Recombinant DNA Technology Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=8233&type=smp

    What Are the Main Drivers Behind the Growth of the recombinant dna technology Market?

    The growth of the recombinant DNA technology market is anticipated to be driven by the escalating prevalence of chronic diseases. Defined as health conditions that persist for at least a year, chronic diseases call for continuous medical attention, limit routine activities, or both. Recombinant DNA technology enhances healthcare by producing biopharmaceutical proteins incorporated in pharmaceuticals and supplanting faulty genes with functional ones through gene therapy, with the goal of curing diseases. For example, a WHO report in April 2021, disclosed that noncommunicable diseases (NCDs) were responsible for 41 million annual deaths, or 71% of all global mortality. Between the ages of 30 and 69, over 15 million people lose their lives to an NCD annually; 85% of these premature deaths occur in low and middle-income countries. Hence, the surge in chronic diseases is fuelling the expansion of the recombinant DNA technology market.

    What Are the Fundamental Segments in the Recombinant DNA Technology Market?

    The recombinant dna technology market covered in this report is segmented –

    1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing

    2) By Component Type: Expression System, Cloning Vector

    3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types

    4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types

    Which Trends Are Revolutionizing the Recombinant DNA Technology Market?

    Technological progression is a predominant trend in the recombinant DNA technology industry. Renowned firms in this sector are concentrating on the development of new technologies to maintain their market stance. For example, Thermo Fisher Scientific, an American enterprise specialising in scientific tools, reagents, consumables, and software services, announced the launch of the Applied Biosystem QuantStudio Absolute Q-Digital PCR System in October 2021. This is the first fully incorporated digital PCR device designed to deliver highly accurate and trustworthy results in genetic analysis and research within 90 minutes. The QuantStudio Absolute Q System employs microfluidic array technology and simplifies methods, unlike the complex, multi-instrument tasks required by traditional dPCR, to enhance data precision and uniformity. The QuantStudio Absolute Q solution offers an efficient, effortless procedure that yields high-quality data with minimal manual intervention. It combines the processes of data gathering, heat cycling, and digitization required for dPCR into a single unit.

    Order Now for Fast Delivery of Your Recombinant DNA Technology Market Report!

    https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

    Which Geographical Regions Are Pioneering Growth in the Recombinant DNA Technology Market?

    North America was the largest region in the recombinant DNA technology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant dna technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Recombinant DNA Technology Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the recombinant dna technology market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Recombinant DNA Technology Market Include

    1. Recombinant DNA Technology Market Executive Summary

    2. Recombinant DNA Technology Market Segments

    3. Recombinant DNA Technology Market Size And Template Market Growth Rate

    4. Key Recombinant DNA Technology Market Trends

    5. Major Recombinant DNA Technology Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Recombinant DNA Technology Market

    26. Top Recombinant DNA Technology Companies

    27. Recombinant DNA Technology Market Opportunities And Strategies

    28. Recombinant DNA Technology Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Laser Weapon Systems Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/laser-weapon-systems-global-market-report

    Smart Weapons Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/smart-weapons-global-market-report

    Autonomous Military Weapons Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/autonomous-military-weapons-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Recombinant DNA Technology Market 2024

    5 Key Insights On The Recombinant DNA Technology Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Recombinant DNA Technology Global Market Report 2024, the recombinant DNA technology market is expected to show significant growth in the forecast period.

    The recombinant DNA technology market has witnessed robust growth in recent years and is poised for further expansion. Key factors driving this surge include healthcare demands, the growth of the biopharmaceutical industry, increased investments in research and development (R&D), and the emergence of personalized medicine. In this blog, we delve into the market’s current status, forecasted growth, and the influential trends shaping its trajectory.

    Market Expansion from 2023 to 2024

    The market size is set to soar from $816.9 billion in 2023 to $882.04 billion in 2024, boasting a compound annual growth rate (CAGR) of 8.0%. This robust growth is attributed to various factors, including the rising prevalence of chronic diseases and the proliferation of biotech startups. Let’s explore the driving forces behind this surge.

    Rising Prevalence Of Chronic Diseases To Drive Market Growth

    The escalating number of chronic diseases is a primary catalyst for the recombinant DNA technology market’s growth. Chronic diseases, persisting for a year or longer, have witnessed a surge, demanding continuous medical care. Recombinant DNA technology plays a pivotal role by improving healthcare through the creation of biopharmaceutical proteins used in pharmaceuticals and facilitating gene therapy. Notably, noncommunicable diseases (NCDs) accounted for 71% of global deaths, emphasizing the critical role of advanced technologies in addressing these health challenges.

    • Recombinant DNA technology addresses chronic diseases by creating biopharmaceuticals and gene therapies.
    • WHO reports highlight the significant global impact of noncommunicable diseases.

    Key Market Players

    Major players driving the recombinant DNA technology market include Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., and more. These industry giants contribute to market growth by leveraging their expertise and resources.

    View More On The Recombinant DNA Technology Market Report 2024 – https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

    Technological Advancements Driving Innovation In Recombinant DNA Technology Market

    Technological advancements stand out as a prominent trend shaping the recombinant DNA technology market. Industry leaders are investing in cutting-edge technologies to maintain a competitive edge. For example, Thermo Fisher Scientific’s introduction of the Applied Biosystem QuantStudio Absolute Q-Digital PCR System exemplifies the commitment to innovation. This system streamlines genetic analysis, delivering precise and reliable results in under 90 minutes. Additionally, Thermo Fisher’s strategic acquisition of PeproTech in January 2022 fortifies its position by integrating PeproTech’s recombinant proteins portfolio into its offerings.

    • Technological advancements, such as Thermo Fisher’s QuantStudio Absolute Q System, enhance precision in genetic analysis.
    • Strategic acquisitions, like Thermo Fisher’s acquisition of PeproTech, strengthen companies’ capabilities and market presence.

    Market Segmentation

    The recombinant DNA technology market is segmented based on various criteria, providing a nuanced understanding of its dynamics. Key segments include product type, component type, application type, and end-use type. These segments offer insights into the diverse applications and industries driving the market.

    1. Product Type:
      • Recombinant Protein Drugs
      • Vaccines
      • Genetically Modified Crops
      • Expression Systems
      • Cell and Gene Therapy
      • Gene Editing
    2. Component Type:
      • Expression System
      • Cloning Vector
    3. Application Type:
      • Food And Agriculture
      • Health And Disease
      • Environment
      • Other Application Types
    4. End-Use Type:
      • Biotechnology And Pharmaceutical Companies
      • Academic And Government Research Institutes
      • Other End-Use Types

    Regional Insights

    In 2023, North America led the recombinant DNA technology market, while the Asia-Pacific region is anticipated to be the fastest-growing region in the forecast period. This shift reflects the global nature of the biotech industry and its expanding footprint across diverse geographical regions.

    Request A Sample Of The Global Recombinant DNA Technology Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=8233&type=smp